Efficacy and safety of sacubitril-valsartan in patients with heart failure: a systematic review and meta-analysis of randomized clinical trials
Author:
Funder
Science and Technology Project of Huizhou
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
General Medicine
Reference33 articles.
1. Prevalence of heart failure and other risk factors among first-degree relatives of women with peripartum cardiomyopathy;Christiansen;Heart,2019
2. Recent advances in cardio-oncology: a report from the ’Heart Failure Association 2019 and World Congress on Acute Heart Failure 2019’;Anker;ESC Heart Fail,2019
3. Role of gender, age and BMI in prognosis of heart failure;Sciomer;Eur J Prev Cardiol,2020
4. Prognosis and NT-proBNP in heart failure patients with preserved versus reduced ejection fraction;Salah;Heart,2019
5. Extended-release oral milrinone for the treatment of heart failure with preserved ejection fraction;Nanayakkara;J Am Heart Assoc,2020
Cited by 4 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. ACE inhibitors and their interaction with systems and molecules involved in metabolism;Heliyon;2024-01
2. Comparison of Outcomes Between Sacubitril/Valsartan and Enalapril in Patients With Heart Failure: A Systematic Review and Meta-Analysis;Cureus;2023-11-10
3. Sacubitril/Valsartan in Heart Failure Hospitalization: Two Pills a Day to Keep Hospitalizations Away?;Cureus;2023-04-09
4. Efficacy and safety profile of angiotensin receptor neprilysin inhibitors in the management of heart failure: a systematic review and meta-analysis of randomized controlled trials;Heart Failure Reviews;2022-10-03
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3